» Articles » PMID: 35298500

Seroepidemiology of SARS-CoV-2 in Healthcare Personnel Working at the Largest Tertiary COVID-19 Referral Hospitals in Mexico City

Abstract

Introduction: We performed a longitudinal SARS-CoV-2 seroepidemiological study in healthcare personnel of the two largest tertiary COVID-19 referral hospitals in Mexico City.

Methods: All healthcare personnel, including staff physicians, physicians in training, nurses, laboratory technicians, researchers, students, housekeeping, maintenance, security, and administrative staff were invited to voluntarily participate, after written informed consent. Participants answered a computer-assisted self-administered interview and donated blood samples for antibody testing every three weeks from October 2020 to June 2021.

Results: A total of 883 participants (out of 3639 registered employees) contributed with at least one blood sample. The median age was 36 years (interquartile range: 28-46) and 70% were women. The most common occupations were nurse (28%), physician (24%), and administrative staff (22%). Two hundred and ninety participants (32.8%) had a positive-test result in any of the visits, yielding an overall adjusted prevalence of 33.5% for the whole study-period. Two hundred and thirty-five positive tests were identified at the baseline visit (prevalent cases), the remaining 55 positive tests were incident cases. Prevalent cases showed associations with both occupational (institution 2 vs. 1: adjusted odds ratio [aOR] = 2.24, 95% confidence interval [CI]: 1.54-3.25; laboratory technician vs. physician: aOR = 4.38, 95% CI: 1.75-10.93) and community (municipality of residence Xochimilco vs. Tlalpan: aOR = 2.03, 95% CI: 1.09-3.79) risk-factors. The incidence rate was 3.0 cases per 100 person-months. Incident cases were associated with community-acquired risk, due to contact with suspect/confirmed COVID-19 cases (HR = 2.45, 95% CI: 1.21-5.00).

Conclusions: We observed that between October 2020 and June 2021, healthcare workers of the two largest tertiary COVID-19 referral centers in Mexico City had similar level of exposure to SARS-CoV-2 than the general population. Most variables associated with exposure in this setting pointed toward community rather than occupational risk. Our observations are consistent with successful occupational medicine programs for SARS-CoV-2 infection control in the participating institutions but suggest the need to strengthen mitigation strategies in the community.

Citing Articles

SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City.

Soto-Nava M, Davila-Conn V, Venancio-Rocha J, Garcia-Esparza P, Tapia-Trejo D, Hernandez-Juan R Virol J. 2023; 20(1):300.

PMID: 38102622 PMC: 10724955. DOI: 10.1186/s12985-023-02261-2.


Seroepidemiology of SARS-CoV-2 Virus in Healthcare Workers before Circulation of the Omicron Sublineages BA.4/BA.5 in Vojvodina, Serbia.

Ristic M, Vukovic V, Patic A, Markovic M, Petrovic V Vaccines (Basel). 2022; 10(12).

PMID: 36560578 PMC: 9783630. DOI: 10.3390/vaccines10122168.


Update Alert 11: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers.

Chou R, Dana T, Buckley D, Selph S, Fu R, Totten A Ann Intern Med. 2022; 175(8):W83-W84.

PMID: 35816711 PMC: 9380720. DOI: 10.7326/L22-0235.

References
1.
Riester E, Findeisen P, Hegel J, Kabesch M, Ambrosch A, Rank C . Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay. J Virol Methods. 2021; 297:114271. PMC: 8393518. DOI: 10.1016/j.jviromet.2021.114271. View

2.
Munoz-Medina J, Grajales-Muniz C, Salas-Lais A, Fernandes-Matano L, Lopez-Macias C, Monroy-Munoz I . SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020. Microorganisms. 2021; 9(4). PMC: 8071542. DOI: 10.3390/microorganisms9040850. View

3.
Noor M, Haq M, Haq N, Amin S, Rahim F, Bahadur S . Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?. Cureus. 2020; 12(11):e11389. PMC: 7654561. DOI: 10.7759/cureus.11389. View

4.
Gomez-Ochoa S, Franco O, Rojas L, Raguindin P, Roa-Diaz Z, Minder Wyssmann B . COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol. 2020; 190(1):161-175. PMC: 7499478. DOI: 10.1093/aje/kwaa191. View

5.
Akinbami L, Vuong N, Petersen L, Sami S, Patel A, Lukacs S . SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020. Emerg Infect Dis. 2020; 26(12):2863-2871. PMC: 7706918. DOI: 10.3201/eid2612.203764. View